https://medicaex.com/prnewswire/the-international-leading-four-patents-of-original-dha-dairy-products/ 2022-12-07T14:12:13+00:00 https://medicaex.com/prnewswire/lunit-highlights-the-effectiveness-of-ai-in-acceleration-of-immunotherapy-research-findings-to-be-presented-at-sitc-2022/ 2022-12-07T12:12:20+00:00 https://medicaex.com/prnewswire/ascletis-announces-ind-approval-of-oral-3clpro-inhibitor-asc11-for-covid-19-by-china-nmpa/ 2022-12-07T11:13:11+00:00 https://medicaex.com/prnewswire/akeso-inc-announces-collaboration-and-license-agreement-for-up-to-us5-billion-with-summit-therapeutics-to-accelerate-global-development-and-commercialization-of-its-breakthrough-bispecific-antibody/ 2022-12-07T05:12:21+00:00 https://medicaex.com/prnewswire/seoul-national-university-bundang-hospital-presents-study-of-sk-biopharmaceuticals-seizure-detection-wearable-device-at-aes-2022/ 2022-12-07T02:12:24+00:00 https://medicaex.com/prnewswire/qilu-pharmaceutical-releases-latest-results-of-ql1604-plus-chemotherapy-as-first-line-treatment-for-patients-with-advanced-cervical-cancer-in-the-phase-ii-study-at-esmo-asia-congress-2022/ 2022-12-07T00:12:39+00:00 https://medicaex.com/prnewswire/clarivate-expands-real-world-data-and-analytics-solutions-with-addition-of-u-s-specialty-pharmacy-data/ 2022-12-07T00:12:35+00:00 https://medicaex.com/prnewswire/university-of-tokyo-and-sekisui-house-launch-joint-research-on-biodiversity-and-health-2/ 2022-12-06T23:12:18+00:00 https://medicaex.com/prnewswire/jellox-biotech-leads-research-in-3d-cancer-pathology-as-nci-explores-potential/ 2022-12-06T14:12:31+00:00 https://medicaex.com/prnewswire/qilu-pharmaceutical-releases-latest-results-of-ql1706-plus-chemotherapy-bevacizumab-for-the-treatment-of-non-small-cell-lung-cancer-in-the-phase-ii-study-at-esmo-asia-congress-2022/ 2022-12-06T13:12:31+00:00 https://medicaex.com/prnewswire/meihua-international-medical-technologies-co-ltd-appoints-new-ceo-cfo-and-directors/ 2022-12-06T13:12:23+00:00 https://medicaex.com/prnewswire/kintor-pharma-announced-the-primary-endpoint-of-phase-ii-clinical-study-for-kx-826s-treatment-of-female-androgenetic-alopecia-in-china-was-met/ 2022-12-06T12:12:30+00:00 https://medicaex.com/prnewswire/lucidity-phase-3-topline-data-presented-at-ctad-for-hmtm-the-only-oral-anti-tau-therapy-in-late-stage-development/ 2022-12-06T12:12:30+00:00 https://medicaex.com/prnewswire/lakeshore-acquisition-corp-i-shareholders-approve-business-combination-with-prosomnus/ 2022-12-06T12:12:26+00:00 https://medicaex.com/prnewswire/china-pharma-holdings-inc-announced-the-acquisition-of-dry-eye-disease-therapeutic-device-project/ 2022-12-06T12:12:21+00:00 https://medicaex.com/prnewswire/zhongchao-inc-established-sid-liver-cancer-comprehensive-disciplinary-physician-education-platform/ 2022-12-06T10:12:20+00:00 https://medicaex.com/prnewswire/menarini-group-presents-updated-results-from-pivotal-phase-3-emerald-trial-at-the-2022-san-antonio-breast-cancer-symposium-sabcs-that-demonstrate-elacestrants-pfs-increases-with-duration-of-prior/ 2022-12-06T09:13:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/MENARINI_GROUP_Logo-F48Hrl.jpeg https://medicaex.com/prnewswire/akesos-ivonescimab-pd-1-vegf-bispecific-antibody-ak112-granted-breakthrough-therapy-designation-for-i-o-resistance-nsclc-patients-in-china/ 2022-12-06T09:12:51+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo_Logo-FZuaZ6.jpeg https://medicaex.com/prnewswire/waterdrop-inc-announces-third-quarter-2022-unaudited-financial-results/ 2022-12-06T09:12:37+00:00 https://medicaex.com/prnewswire/university-of-tokyo-and-sekisui-house-launch-joint-research-on-biodiversity-and-health/ 2022-12-06T07:13:14+00:00 https://medicaex.com/prnewswire/epiprotect-reduces-the-cost-for-treatment-of-hard-to-heal-leg-ulcers-with-83/ 2022-12-06T03:12:28+00:00 https://medicaex.com/prnewswire/armis-named-clear-leader-in-spark-matrix-for-connected-medical-device-security-solutions/ 2022-12-06T03:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/12/Armis_Logo-NsylWy.jpeg https://medicaex.com/prnewswire/the-first-ibcc-unveiled-in-hainan/ 2022-12-06T03:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/12/Asieris_Unveiling_Ceremony-nwqxMn.jpeg https://medicaex.com/prnewswire/asia-pacific-experts-uncover-gender-based-disparity-in-diagnosis-treatment-and-management-of-atrial-fibrillation-2/ 2022-12-06T03:12:13+00:00 https://medicaex.com/prnewswire/aloe-vera-of-america-receives-award-for-environmental-health-efforts/ 2022-12-06T03:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/Forever_Living_Products_International___Blue_Thumb_Award-u0XNQm.jpeg https://medicaex.com/prnewswire/s3-connected-health-receives-frost-sullivans-award-for-helping-medical-device-companies-create-custom-connected-medical-device-solutions/ 2022-12-06T01:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/12/S3_Connected_Health_Award-OSgpFa.jpeg https://medicaex.com/prnewswire/innovent-and-union-therapeutics-announce-first-subject-dosed-in-a-chinese-clinical-phase-i-study-of-the-novel-pde4-inhibitor-orismilast-ibi353/ 2022-12-06T01:12:20+00:00 https://medicaex.com/prnewswire/ascletis-announces-completion-of-180-patient-enrollment-for-phase-ii-clinical-trial-of-fasn-inhibitor-asc40-for-acne/ 2022-12-06T00:12:31+00:00 https://medicaex.com/prnewswire/lynk-pharmaceuticals-announces-first-patient-dosed-in-phase-%e2%85%b1-clinical-study-of-lnk01003-in-patients-with-ulcerative-colitis/ 2022-12-05T14:12:31+00:00 https://medicaex.com/prnewswire/prenetics-announces-us20-million-stock-repurchase-program-and-inclusion-into-the-msci-global-micro-cap-index/ 2022-12-05T13:12:35+00:00 https://medicaex.com/prnewswire/a-bispecific-antibody-molecule-jointly-developed-by-buchang-pharmaceutical-and-remd-biotherapeutics-partners-of-genscript-probio-received-ind-clearance-from-nmpa-for-clinical-trial/ 2022-12-05T12:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/12/GENSCRIPT_Logo-NAJ83y.jpeg https://medicaex.com/prnewswire/cardiac-troponin-diagnostics-market-growth-boosted-by-high-sensitivity-point-of-care-testing/ 2022-12-05T12:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/12/GettyImages_1329733718-5Y5gnY.jpeg https://medicaex.com/prnewswire/china-pharma-announces-receipt-of-noncompliance-notice-from-nyse-american/ 2022-12-05T12:12:21+00:00 https://medicaex.com/prnewswire/united-imaging-selected-to-academy-of-radiology-biomedical-imaging-researchs-council-of-distinguished-investigators-class-of-2022/ 2022-12-05T08:13:46+00:00 https://medicaex.com/prnewswire/foundation-for-angelman-syndrome-therapeutics-fast-announces-5-million-gift-to-advance-clinical-trials-in-rare-neurodevelopmental-disorders/ 2022-12-05T08:13:39+00:00 https://medicaex.com/wp-content/uploads/2022/12/FAST_Logo_Logo-2bS26y.jpeg https://medicaex.com/prnewswire/we-are-one-completes-the-largest-blood-donation-in-history-with-70000-volunteers/ 2022-12-05T02:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/We_are_One__completes_the_largest_blood_donation_in_history_with_70_000_volunteers-gddglL.jpeg https://medicaex.com/prnewswire/genfleet-therapeutics-to-present-data-from-phase-i-trial-of-gfh009-monotherapy-at-the-2022-annual-meeting-of-american-society-of-hematology-ash/ 2022-12-05T00:12:29+00:00 https://medicaex.com/prnewswire/etiometry-applauded-by-frost-sullivan-for-enabling-timely-decision-support-for-critical-care-with-its-digital-and-automated-solution/ 2022-12-05T00:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/12/Etiometry_Award-9UIMhS.jpeg https://medicaex.com/prnewswire/cure-brain-cancer-foundation-rings-nasdaq-opening-bell-announces-u-s-expansion/ 2022-12-05T00:12:19+00:00 https://medicaex.com/prnewswire/sirolimus-coated-balloon-in-btk-treatment-makes-a-bold-presence-at-veith-2022-lights-up-ny-times-square-nasdaq/ 2022-12-05T00:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/12/Edward_Choke_MagicTouch_XTOSI-mV3pFS.jpeg https://medicaex.com/prnewswire/focus-x-therapeutics-a-viva-biotech-portfolio-company-successfully-reached-an-acquisition-agreement-with-full-life-technologies/ 2022-12-05T00:12:19+00:00 https://medicaex.com/prnewswire/telix-announces-executive-leadership-appointments/ 2022-12-04T23:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/12/Telix_Main_Logo_Logo-aMwJ05.jpeg https://medicaex.com/prnewswire/lyvgen-announces-phase-2-clinical-collaboration-with-bristol-myers-squibb-to-evaluate-lvgn7409-in-combination-with-nivolumab-in-non-small-cell-lung-cancer-patients/ 2022-12-04T09:12:47+00:00 https://medicaex.com/wp-content/uploads/2022/12/Lyvgen_Biopharma_Logo-aWqaL6.jpeg https://medicaex.com/prnewswire/cambridge-cognition-and-luca-healthcare-announce-a-strategic-partnership-and-an-exclusive-licensing-agreement-to-commercialize-cambridge-cognitions-suite-of-cognitive-assessment-tools-and-brain-heal/ 2022-12-04T09:12:43+00:00 https://medicaex.com/prnewswire/parnell-pharmaceuticals-holdings-ltd-announces-proposed-rights-offering/ 2022-12-04T09:12:36+00:00 https://medicaex.com/prnewswire/2nd-global-forum-of-peoples-organizations-on-hansens-disease-focuses-on-capacity-building-to-promote-dignity-of-those-affected-by-the-disease/ 2022-12-03T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/12/The_1st_Global_Forum_People_s_Organizations_Hansen_s_Disease_held_Manila-nQdSUL.jpeg https://medicaex.com/prnewswire/chemotherapy-may-be-completed-within-8-days-with-two-doses-of-polytaxel-an-innovative-anticancer-drug-from-south-koreas-biotech-firm/ 2022-12-03T02:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/12/Image__Hyundai_Bioscience_Polytaxel_entering_clinical_trial-nAFiou.jpeg https://medicaex.com/prnewswire/full-life-technologies-to-acquire-focus-x-therapeutics-bolstering-peptide-focused-radiopharmaceutical-pipeline/ 2022-12-03T02:12:27+00:00 https://medicaex.com/prnewswire/jacobios-preclinical-results-of-kras-g12c-inhibitor-in-combination-with-shp2-inhibitor-will-be-presented-at-the-esmo-asia-congress-2022/ 2022-12-03T02:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo-waT6eI.jpeg https://medicaex.com/prnewswire/medeologix-acquires-three-silicon-valley-medical-device-cdmo-companies-and-establishes-one-stop-shop-mass-production-facilities-in-taiwan/ 2022-12-02T21:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/12/medeologix_Logo-gntHoe.jpeg https://medicaex.com/prnewswire/innoforce-opens-gmp-manufacturing-facility-corporate-headquarters-in-hangzhou-china-to-provide-cdmo-services-for-global-supply-of-rna-cell-gene-therapies/ 2022-12-02T21:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/12/Innoforce_Pharmaceuticals_Logo-aPsY8x.jpeg https://medicaex.com/prnewswire/havas-health-you-expands-content-expertise-through-partnership-with-evermed/ 2022-12-02T17:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/12/Evermed_CEO_Bozidar_Jovicevic_H_H_Y-PmCKWm.jpeg https://medicaex.com/prnewswire/creating-the-leaders-of-tomorrow-the-valuable-500-reach-milestone-for-generation-valuable-on-international-day-for-persons-with-disabilities/ 2022-12-02T16:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/12/Generation_Valuable-Wqkf2k.jpeg https://medicaex.com/prnewswire/biovaxys-announces-successful-test-run-production-of-its-bi-haptenized-ovarian-cancer-vaccine/ 2022-12-02T15:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/12/BIOVAXYS_Logo-D5cM3L.jpeg https://medicaex.com/prnewswire/111-inc-announces-third-quarter-2022-unaudited-financial-results/ 2022-12-02T10:12:22+00:00 https://medicaex.com/prnewswire/mabwell-announces-the-u-s-fda-approval-of-9mw3011-fic-for-ind/ 2022-12-02T08:13:43+00:00 https://medicaex.com/prnewswire/encore-medical-education-announces-publication-of-the-official-best-of-sabcs-news-highlights-summarizing-key-trial-results-from-the-2022-sabcs/ 2022-12-02T08:13:32+00:00 https://medicaex.com/wp-content/uploads/2022/12/SABCS_Logo-ryhybD.jpeg https://medicaex.com/prnewswire/waterdrop-inc-to-report-third-quarter-2022-financial-results-on-december-6-2022/ 2022-12-02T04:12:11+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-names-donghoon-lee-head-of-bio-investment-center-of-sk-inc-as-new-ceo/ 2022-12-02T02:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo-xcM0A3.jpeg https://medicaex.com/prnewswire/new-crispr-cas9-license-agreement-for-ers-genomics-and-cosmo-bio/ 2022-12-02T00:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/12/ERS_Genomics_CEO-Hb0VMd.jpeg https://medicaex.com/prnewswire/new-study-on-deep-learning-technology-for-improving-mri-image-quality-published-in-european-radiology/ 2022-12-01T14:12:35+00:00 https://medicaex.com/prnewswire/kira-pharmaceuticals-announces-first-cohort-of-patients-dosed-in-phase-2-study-of-kp104-in-paroxysmal-nocturnal-hemoglobinuria-pnh/ 2022-12-01T13:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/12/Kira_Pharmaceuticals_Logo-85voU5.jpeg https://medicaex.com/prnewswire/commercial-dishwashers-destroy-protective-layer-in-gut/ 2022-12-01T13:12:17+00:00 https://medicaex.com/prnewswire/rokid-and-eyedaptic-launch-eye5-to-help-amd-patients-enhance-their-vision/ 2022-12-01T11:13:00+00:00 https://medicaex.com/prnewswire/global-alliance-of-heart-patient-organizations-unveils-new-global-cholesterol-action-plan-to-prioritize-unhealthy-cholesterol-as-a-main-public-health-issue/ 2022-12-01T07:12:18+00:00 https://medicaex.com/prnewswire/wuxi-apptec-receives-2022-global-contract-research-development-and-manufacturing-organization-company-of-the-year-award-from-frost-sullivan/ 2022-12-01T07:12:18+00:00 https://medicaex.com/prnewswire/digital-technologies-driving-transformational-growth-across-the-biomanufacturing-value-chain/ 2022-12-01T00:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/12/biomanufacturing-C7k1v5.jpeg https://medicaex.com/prnewswire/anchordx-enrolls-the-first-patient-for-its-urifind-bladder-cancer-assay-clinical-trial-in-the-u-s/ 2022-11-30T19:12:36+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo-MWsNSs.jpeg https://medicaex.com/prnewswire/j-ints-bio-m-d-anderson-cancer-center-joint-development-oral-hsp90-inhibitor-jin-001-presentation-of-preclinical-assessment-at-2022-sno-annual-meeting/ 2022-11-30T16:13:19+00:00 https://medicaex.com/wp-content/uploads/2022/12/J_INTS_BIO_CI-HyQ1Jj.jpeg https://medicaex.com/prnewswire/vuno-showcases-their-ai-solutions-and-research-results-at-rsna-2022/ 2022-11-30T16:13:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/Meet_VUNO_at_RSNA_2022-tYOVQ9.jpeg https://medicaex.com/prnewswire/neurophet-to-participate-in-the-radiological-society-of-north-america-rsna-2022/ 2022-11-30T14:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/Neurophet__to_participate_in_the_Radiological_Society_of_North_America_RSNA_2022-kvQMub.jpeg https://medicaex.com/prnewswire/tiangen-to-roll-out-a-stunning-automated-solution-at-cell-bio-2022/ 2022-11-30T14:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/mandatory-2XWQPY.jpeg https://medicaex.com/prnewswire/first-patient-dosed-in-phase-ii-ipax-linz-study-of-tlx101-for-glioblastoma-therapy/ 2022-11-30T12:12:50+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-PjQufz.jpeg https://medicaex.com/prnewswire/yuyu-pharma-plans-to-enter-the-u-s-and-european-markets-for-hair-loss-treatment/ 2022-11-30T12:12:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/2-mfFCxz.jpeg https://medicaex.com/prnewswire/targedys-and-symbiopharm-enter-an-exclusive-partnership-to-launch-symbiolife-satylia-in-germany/ 2022-11-30T12:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/TargEDys_SymbioPharm_Logo-0TTFRL.jpeg https://medicaex.com/prnewswire/concord-medical-schedules-2022-annual-meeting-of-shareholders/ 2022-11-30T08:12:33+00:00 https://medicaex.com/prnewswire/probiotic-strain-snz-1969-helps-manage-ibs-d-ibs-c-symptoms-effectively-latest-clinical-study-shows/ 2022-11-30T08:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/SNZ_1969-7MCQ7D.jpeg https://medicaex.com/prnewswire/aroa-biosurgery-announces-half-year-results/ 2022-11-30T08:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/AROA_logo-476mvx.jpeg https://medicaex.com/prnewswire/navigating-a-perfect-storm-driving-access-to-healthcare-in-emerging-markets/ 2022-11-30T08:12:13+00:00 https://medicaex.com/prnewswire/first-patient-dosed-in-a-head-to-head-first-line-bridging-study-of-hansizhuang-for-es-sclc-treatment-in-the-us/ 2022-11-30T01:12:19+00:00 https://medicaex.com/prnewswire/infinitus-co-organizes-the-2022-responsibilities-for-health-forum/ 2022-11-30T01:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/CEO-O5P7sp.jpeg https://medicaex.com/prnewswire/cosmax-group-expands-business-to-pet-care-targeting-200b-market/ 2022-11-29T15:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pet_Care_Products_Developed_COSMAX-nYGBpn.jpeg https://medicaex.com/prnewswire/venus-medtech-to-showcase-its-structural-heart-treatments-at-london-valves-2022/ 2022-11-29T14:12:40+00:00 https://medicaex.com/prnewswire/mintal-tracker-wins-highest-honor-from-prestigious-2022-fall-digital-health-awards/ 2022-11-29T14:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5025239_70739092-B2NMZw.jpeg https://medicaex.com/prnewswire/united-imaging-drives-forward-several-major-innovations-in-multiple-imaging-modalities/ 2022-11-29T13:12:44+00:00 https://medicaex.com/prnewswire/xtalpi-and-ck-life-sciences-to-collaborate-in-ai-empowered-tumour-vaccine-research-and-development-opening-a-new-paradigm-for-scientific-innovation/ 2022-11-29T13:12:36+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-nBmikE.jpeg https://medicaex.com/prnewswire/building-a-fitness-community-kl-wellness-city-fitness-fiesta-offers-free-and-fun-activities-for-all-sponsors-staff-to-ironman-western-australia/ 2022-11-29T09:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/WhatsApp_Image_2022_11_29_at_15_37_02-CwknwQ.jpeg https://medicaex.com/prnewswire/detectedx-introduces-imagedx-to-transform-image-based-education-at-rsna/ 2022-11-29T08:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/detectedx_Logo-bWO23V.jpeg https://medicaex.com/prnewswire/vieworks-exhibits-at-rsna-2022-with-its-complete-lineup-of-next-generation-x-ray-flat-panel-detectors/ 2022-11-29T02:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_1-ZRY8Xd.jpeg https://medicaex.com/prnewswire/ascletis-announces-ind-filing-of-oral-3clpro-inhibitor-asc11-for-covid-19-accepted-by-china-nmpa/ 2022-11-29T01:12:20+00:00 https://medicaex.com/prnewswire/bgi-genomics-naleya-genomics-indonesia-mgi-and-bumame-contribute-aid-packages-to-cianjur-earthquake-relief-efforts/ 2022-11-29T01:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bumame_BGI_representatives_visit_Cianjur_contribute_relief_efforts-rrcQAH.jpeg https://medicaex.com/prnewswire/peptrons-pt105-a-sustained-release-leuprolide-established-the-bioequivalence-with-takedas-leuplin/ 2022-11-29T00:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-xqW1Z3.jpeg https://medicaex.com/prnewswire/everest-medicines-announces-major-regulatory-updates-in-taiwan-and-south-korea-for-nefecon-for-the-treatment-of-primary-iga-nephropathy/ 2022-11-28T15:12:31+00:00 https://medicaex.com/prnewswire/lunit-becomes-the-first-medical-software-company-in-asia-pacific-to-become-mdr-ce-and-ukca-certified/ 2022-11-28T13:12:40+00:00 https://medicaex.com/prnewswire/j-ints-bio-novel-oral-4th-generation-egfr-tki-jin-a02-phase-1-2-ind-approved-by-us-fda/ 2022-11-28T13:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/J_INTS_BIO_CI-xzTjWY.jpeg https://medicaex.com/prnewswire/innovent-announced-clinical-data-of-multiple-trials-will-be-presented-at-the-2022-esmo-io-and-ash-annual-meetings/ 2022-11-28T13:12:29+00:00 https://medicaex.com/prnewswire/izion24-the-first-pocket-insurance-app-in-vietnam-determines-to-protect-millions-of-people/ 2022-11-28T12:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5020091_29341036-wiczaf.jpeg https://medicaex.com/prnewswire/rvac-medicines-and-astar-to-build-capabilities-for-mrna-production-in-singapore/ 2022-11-28T11:12:58+00:00 https://medicaex.com/prnewswire/open-health-appoints-david-p-king-as-non-executive-chairman-and-paul-carter-as-independent-board-member/ 2022-11-28T10:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/OH_Logo_Main_Logo-rRnquw.jpeg https://medicaex.com/prnewswire/colotect-non-invasive-colorectal-cancer-screening-test-has-been-launched-in-southeast-asia/ 2022-11-28T09:12:28+00:00 https://medicaex.com/prnewswire/a-new-start-learn-grow-and-thrive-at-ibhe-tsinghua-sigs/ 2022-11-28T09:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_1-748vTk.jpeg https://medicaex.com/prnewswire/telehealth-usage-in-asia-pacific-for-people-living-with-hiv-increasing-but-data-privacy-and-lack-of-personal-contact-still-seen-as-a-barrier-to-wider-use/ 2022-11-28T08:12:24+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gilead_Sciences_Logo-OhmdqU.jpeg https://medicaex.com/prnewswire/nuance-pharma-announces-partnership-with-dksh-to-launch-bentrio-nasal-spray-in-hong-kong-and-macau/ 2022-11-28T06:12:22+00:00 https://medicaex.com/prnewswire/yidu-tech-announces-results-for-the-first-half-of-fy2023-adjusted-net-loss-narrowed-down-30-3-yoy-strategic-focus-enhanced-business-resilience/ 2022-11-28T06:12:15+00:00 https://medicaex.com/prnewswire/peijia-medical-limited-and-inqb8-medical-technologies-llc-report-successful-first-in-human-implantation-of-monarq-transcatheter-tricuspid-valve-replacement-system/ 2022-11-28T01:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/Peijia_Logo-TlRuJ7.jpeg https://medicaex.com/prnewswire/astrazeneca-thailand-wins-two-aces-awards-2022-industry-champions-of-the-year-and-community-initiative/ 2022-11-28T00:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/Image-BYMzM3.jpeg https://medicaex.com/prnewswire/genscript-takes-home-executive-of-the-year-biotechnology-at-the-sbr-management-excellence-awards-2022/ 2022-11-27T23:12:35+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mr_Johnson_Wang_receiving_Executive_The_Year_Biotechnology_category_Award-RmUP3c.jpeg https://medicaex.com/prnewswire/fovia-ai-to-showcase-ai-visualization-integrations-at-iaip-exhibit-rsna-2022/ 2022-11-27T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Imaging_Artificial_Intelligence_in_Practice_2022for_press-yVTSKx.jpeg https://medicaex.com/prnewswire/professor-laszlo-tabar-joins-detectedx-as-the-medical-director-of-breast-cancer-imaging/ 2022-11-25T15:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/detectedx_Logo-APBcGk.jpeg https://medicaex.com/prnewswire/triastek-receives-fda-ind-clearance-for-3d-printed-medicine-for-the-treatment-of-ulcerative-colitis/ 2022-11-25T15:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5017147_11354335-hbyc51.jpeg https://medicaex.com/prnewswire/medica-2022-newcomer-scivita-medical-celebrates-trade-show-success-and-the-strategy-of-globalization/ 2022-11-25T14:12:49+00:00 https://medicaex.com/wp-content/uploads/2022/11/MEDICA_2022_Scivita_Medical_s_booth-jCHczX.jpeg https://medicaex.com/prnewswire/med-el-presents-ideas4ears-and-calls-for-child-inventors-to-aim-high-for-people-living-with-hearing-loss/ 2022-11-25T13:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/Aim_high_for_science-pQnRaN.jpeg https://medicaex.com/prnewswire/edenlux-launches-ai-based-service-otus-plus-eye-health-care-report/ 2022-11-25T13:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_819222_5227325-3NGrsO.jpeg https://medicaex.com/prnewswire/building-sustainable-systems-for-all-at-future-of-healthcare-week-asia/ 2022-11-25T11:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/Future_Healthcare_Week_Asia_2022_One_Farrer_Hotel_Singapore-AXuxhQ.jpeg https://medicaex.com/prnewswire/chuv-cern-and-theryq-join-forces-for-a-world-first-in-cancer-radiotherapy/ 2022-11-25T10:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/11/CHUV_and_CERN_and_THERYQ-NX4G8a.jpeg https://medicaex.com/prnewswire/acucort-signs-its-first-commercial-agreement-for-the-companys-drug-zeqmelit/ 2022-11-25T09:12:29+00:00 https://medicaex.com/prnewswire/yiling-pharmaceutical-exhibiting-its-innovative-tcm-products-during-chexpo-macau-2022/ 2022-11-25T08:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lianhua_products__blue_packages__designated_Official_Anti_epidemic_Products_MIF_MFE-xmgHjN.jpeg https://medicaex.com/prnewswire/yao-autonomous-county-for-healthcare-worldwide/ 2022-11-25T07:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/Peace_tree-v6SCtE.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-to-participate-in-two-upcoming-investor-conferences-2/ 2022-11-25T02:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/gracell_logo_Logo-z1skO6.jpeg https://medicaex.com/prnewswire/in-operation-the-most-innovative-11-74t-mri-core-magnet-to-be-used-on-humans/ 2022-11-25T01:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/ASG_Gachon-UdC2xQ.jpeg https://medicaex.com/prnewswire/edenlux-launches-ai-based-service-otus-plus-eye-health-care-report-2/ 2022-11-24T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Edenlux_Otus_Plus_APP-2GmLmy.jpeg https://medicaex.com/prnewswire/hugels-letybo-first-in-korea-to-obtain-marketing-approval-from-australia/ 2022-11-24T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_of_Hugel_Logo-qQkE6V.jpeg https://medicaex.com/prnewswire/astrazeneca-certified-best-place-to-work-in-indonesia-for-2022/ 2022-11-24T14:12:12+00:00 https://medicaex.com/prnewswire/jiangsu-traditional-chinese-medicine-international-exchange-conference-kicked-off-in-nanjing/ 2022-11-24T13:12:57+00:00 https://medicaex.com/prnewswire/sk-bioscience-and-cepi-sign-agreement-to-develop-mrna-vaccines/ 2022-11-24T11:15:56+00:00 https://medicaex.com/wp-content/uploads/2022/11/SK_bioscience_and_CEPI_Sign_Agreement_to_Develop_mRNA_Vaccines-URljcb.jpeg https://medicaex.com/prnewswire/wuxi-apptec-begins-construction-of-wuxi-sta-pharmaceutical-east-china-rd-facility/ 2022-11-24T08:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/image1-jjTKN1.jpeg https://medicaex.com/prnewswire/reistone-biopharmas-oral-ivarmacitinib-meets-primary-endpoint-in-phase-iii-study-for-atopic-dermatitis/ 2022-11-24T04:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/Reistone_Biopharma_logo-RYGbVD.jpeg https://medicaex.com/prnewswire/wise-technology-to-feature-in-upcoming-aphrs-scientific-session/ 2022-11-24T02:12:33+00:00 https://medicaex.com/prnewswire/lunit-partners-with-carpl-ai-to-accelerate-ai-powered-medical-imaging-across-major-overseas-channels/ 2022-11-24T00:12:24+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lunit_CI_Logo-w5HFv7.jpeg https://medicaex.com/prnewswire/ionopticks-ushers-in-a-new-age-of-proteomics-with-aurora-frontier/ 2022-11-23T23:13:11+00:00 https://medicaex.com/prnewswire/the-13th-china-taizhou-international-medical-expo-successfully-held/ 2022-11-23T18:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/Signing_ceremony-fzF6fU.jpeg https://medicaex.com/prnewswire/illuccix-available-on-high-activity-gallium-generator-technology-to-meet-high-demand/ 2022-11-23T17:12:24+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-FBYHJh.jpeg https://medicaex.com/prnewswire/3z-zebrafish-mutant-model-reveals-novel-drug-candidates-for-adhd/ 2022-11-23T16:12:32+00:00 https://medicaex.com/prnewswire/korea-ginseng-corp-as-an-adaptogenic-herb-korean-red-ginseng-boosts-the-human-immune-response/ 2022-11-23T16:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/PR-buUKWi.jpeg https://medicaex.com/prnewswire/kinseed-selects-solaces-event-streaming-and-management-solution-to-accelerate-digital-transformation-in-the-healthcare-industry/ 2022-11-23T15:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Solace_Logo-2zjPYZ.jpeg https://medicaex.com/prnewswire/better-treatments-for-breast-cancer-latest-clinical-data-of-bispecific-antibodies-will-be-presented-at-sabcs-2022-by-alphamab-oncology/ 2022-11-23T14:12:29+00:00 https://medicaex.com/prnewswire/ascletis-announces-ind-approval-of-oral-3clpro-inhibitor-asc11-for-covid-19-by-u-s-fda/ 2022-11-23T12:12:27+00:00 https://medicaex.com/prnewswire/ind-approval-from-the-us-fda-for-theranostic-sar-bombesin-trial-in-prostate-cancer/ 2022-11-23T11:12:26+00:00 https://medicaex.com/prnewswire/oral-care-brand-bitvae-receives-american-dental-association-certificate-for-its-d2-and-s2-smart-electric-toothbrushes/ 2022-11-23T07:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Oral_Care_Brand_Bitvae_Receives_American_Dental_Association_Certificate_for_its_D2_and_S2_Smart_Elec-CGt52z.jpeg https://medicaex.com/prnewswire/interplex-announces-stackable-multi-row-board-to-board-connector-products-that-achieve-unprecedented-flexibility/ 2022-11-23T06:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Interplex-C05Mh2.jpeg https://medicaex.com/prnewswire/umoja-biopharma-and-iaso-biotherapeutics-announce-research-collaboration-to-bring-off-the-shelf-therapies-to-patients-with-hematological-malignancies/ 2022-11-23T04:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/image-8YaMZu.jpeg https://medicaex.com/prnewswire/luvme-cares-for-womens-health-in-alopecia-breast-cancer-themed-charity-events/ 2022-11-22T15:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Poster__alopeciawarrior_event__left__customers__posts_Luvme_Hair_s_Facebook_group-NX6d5Y.jpeg https://medicaex.com/prnewswire/phiskin-rolls-out-upgrade-of-its-one-stop-high-end-medical-service-system/ 2022-11-22T15:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-FkWCq8.jpeg https://medicaex.com/prnewswire/publication-of-the-offering-circular-in-relation-to-the-merger-between-dsm-and-firmenich-and-the-listing-of-dsm-firmenich-on-euronext-amsterdam/ 2022-11-22T08:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Combined_Logo-s6wbHM.jpeg https://medicaex.com/prnewswire/cambrex-to-acquire-snapdragon-chemistry-a-leader-in-continuous-flow-api-development-services/ 2022-11-22T01:14:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cambrex_Logo-ORfkJh.jpeg https://medicaex.com/prnewswire/lumiradx-continues-commercial-expansion-of-its-rapid-microfluidic-immunoassay-hba1c-test/ 2022-11-21T21:12:49+00:00 https://medicaex.com/prnewswire/ainos-publishes-preclinical-data-demonstrating-its-veldona-formulations-potential-as-treatment-candidates-for-the-most-common-medical-conditions-for-companion-animals/ 2022-11-21T21:12:35+00:00 https://medicaex.com/prnewswire/quantivly-exhibits-at-rsna-2022-with-ai-driven-software-to-transform-the-way-radiology-leaders-manage-operations-and-increase-access-to-imaging-for-the-population/ 2022-11-21T16:12:30+00:00 https://medicaex.com/prnewswire/treadwell-therapeutics-announces-presentations-at-the-2022-san-antonio-breast-cancer-symposium-featuring-a-clinical-trial-update-on-the-cfi-402257-and-cfi-400945-programs/ 2022-11-21T15:12:27+00:00 https://medicaex.com/prnewswire/airs-medical-showcases-award-winning-mri-enhancement-ai-solution-at-rsna-2022/ 2022-11-21T14:12:52+00:00 https://medicaex.com/prnewswire/nona-biosciences-enters-into-hcab-based-drug-discovery-collaboration-agreement-with-dragonfly-therapeutics/ 2022-11-21T14:12:35+00:00 https://medicaex.com/wp-content/uploads/2022/11/HB_for_email_Logo-OKAg3r.jpeg https://medicaex.com/prnewswire/lianhua-respiratory-health-products-to-assure-the-smooth-holding-of-hainan-international-health-industry-expo/ 2022-11-21T14:12:35+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5010529_29260856-uWPb78.jpeg https://medicaex.com/prnewswire/olon-international-api-supplier-releases-the-new-sustainability-report-2022-confirming-the-progress-of-its-sustainability-in-the-focus-areas-of-environment-supply-chain-people-community-engagemen/ 2022-11-21T14:12:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/Olon_SpA_logo-0uf0Vk.jpeg https://medicaex.com/prnewswire/mintal-tracker-lets-users-see-their-dreams-again/ 2022-11-21T14:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mintal-B72Y2D.jpeg https://medicaex.com/prnewswire/imaging-endpoints-announces-the-appointment-of-joy-huan-zhu-m-d-ph-d-as-vice-president-medical-operations/ 2022-11-21T13:12:39+00:00 https://medicaex.com/wp-content/uploads/2022/11/IEP_Logo_Logo-OM4amz.jpeg https://medicaex.com/prnewswire/lunit-to-supply-ai-platform-to-australias-breastscreen-nsw-machine-reading-project/ 2022-11-21T13:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lunit_INSIGHT_MMG_a_clinical_setting-UFwhkr.jpeg https://medicaex.com/prnewswire/bgi-group-signs-mous-in-indonesia-to-support-genomics-development/ 2022-11-21T13:12:29+00:00 https://medicaex.com/prnewswire/abbott-launches-panbiotm-hiv-self-test-at-retail-increasing-access-to-faster-reliable-and-discrete-testing-at-home/ 2022-11-21T13:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/Panbio_HIV_Self_Test_Launch__HK__01_white-yUmHYp.jpeg https://medicaex.com/prnewswire/jiangsu-recbio-technology-co-ltd-increases-production-for-the-first-phase-of-manufacturing-facility-with-a-maximum-annual-output-of-20-million-doses-of-recombinant-hpv-9-valent-vaccine/ 2022-11-21T13:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/Recbio_Logo-DWtSJZ.jpeg https://medicaex.com/prnewswire/where-your-days-begin-again-medical-korea/ 2022-11-21T13:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medical_Korea_image-X0hK1F.jpeg https://medicaex.com/prnewswire/redhill-accelerates-opaganibs-nuclear-radiation-protection-program-positive-data-published/ 2022-11-21T12:12:45+00:00 https://medicaex.com/wp-content/uploads/2022/11/RedHill_Biopharma_Logo-cKD2iW.jpeg https://medicaex.com/prnewswire/everise-guatemala-celebrates-10-years-of-delivering-excellent-customer-experience/ 2022-11-21T10:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/EVERISE_Logo-0w8X8P.jpeg https://medicaex.com/prnewswire/genotek-yerevan-armenia-professor-tamara-sarkisian-and-illumina-open-a-world-class-genomic-laboratory/ 2022-11-21T09:12:28+00:00 https://medicaex.com/prnewswire/waterdrop-co-founder-yao-hu-shares-progress-in-pharmaceutical-innovation/ 2022-11-21T08:12:31+00:00 https://medicaex.com/prnewswire/so-young-reports-unaudited-third-quarter-2022-financial-results/ 2022-11-21T08:12:31+00:00 https://medicaex.com/prnewswire/medicox-signs-contract-with-oramed-to-distribute-oral-insulin-in-south-korea/ 2022-11-21T07:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/From_Left__MEDICOX_CEO_Oh_Daehwan_ORAMED_CEO_Nadav_Kidron-PJtRgd.jpeg https://medicaex.com/prnewswire/concord-medical-announces-the-successful-holding-of-the-second-annual-academic-meeting-with-the-world-well-known-md-anderson/ 2022-11-21T04:12:30+00:00 https://medicaex.com/prnewswire/new-study-reveals-the-extent-of-antibiotic-misuse-for-a-common-sore-throat-fuelling-the-3rd-leading-cause-of-death-worldwide/ 2022-11-21T04:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/GRIP_Infographic-YR1k1o.jpeg https://medicaex.com/prnewswire/polyu-researchers-compile-worlds-first-atlas-of-airborne-microbes-that-provides-an-important-new-perspective-for-public-health-research/ 2022-11-21T03:12:31+00:00 https://medicaex.com/prnewswire/coastal-walk-against-domestic-family-violence-returns-sunday-27-november/ 2022-11-21T02:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/Coastal_Walk_2018__I_say_no__Credit_Little_Glimpses_Photography-LlgcUM.jpeg https://medicaex.com/prnewswire/medical-city-ceo-named-most-inspiring-executive-at-aces-awards-2022/ 2022-11-21T02:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/With_40_years_of_medical_and_managerial_experience__most_of_them_in_The_Medical_City__Dr__Eugene_Ram-60bjtP.jpeg https://medicaex.com/prnewswire/u-s-fda-grants-emergency-use-authorization-for-novavax-covid-19-vaccine-adjuvanted-as-a-booster-for-adults/ 2022-11-20T19:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Novavax_High_Res_Logo-iRaQ5T.jpeg https://medicaex.com/prnewswire/what-breakthroughs-are-tsinghuas-labs-making-in-sci-tech-innovation/ 2022-11-18T16:12:14+00:00 https://medicaex.com/prnewswire/standigm-synthetic-research-center-successfully-accelerates-drug-discovery-in-its-first-year/ 2022-11-18T09:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/Standigm_B_W_Logo-rjlMbp.jpeg https://medicaex.com/prnewswire/nuance-pharma-announces-clearance-of-ind-application-for-respiratory-syncytial-virus-rsv-vaccine-in-china/ 2022-11-18T07:14:05+00:00 https://medicaex.com/prnewswire/edan-took-its-solutions-up-a-notch-at-medica-2022/ 2022-11-18T06:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/EDAN___MEDICA_2022_Latest_Innovations_9A60-rwom4j.jpeg https://medicaex.com/prnewswire/remegens-disitamab-vedotin-achieves-first-line-treatment-recommendation-status-for-advanced-urothelial-cancer-in-updated-2022-csco-guidelines/ 2022-11-18T06:12:24+00:00 https://medicaex.com/prnewswire/accelerating-its-international-development-the-april-group-establishes-an-entity-in-germany/ 2022-11-18T00:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/APRIL_Group_Logo-CA9TMm.jpeg https://medicaex.com/prnewswire/the-sigourney-award-2022-honors-five-recipients-for-outstanding-work-advancing-psychoanalytic-principles-globally/ 2022-11-17T23:13:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_sigourney_winners_ALL_UP_square-ryoR2N.jpeg https://medicaex.com/prnewswire/the-grand-hamdan-award-goes-to-two-scientists-in-australia/ 2022-11-17T19:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Grand_Hamdan_Award_1-JBn9y4.jpeg https://medicaex.com/prnewswire/asa-ren-and-g42-healthcare-team-up-to-advance-genomic-sequencing-and-bioinformatics-in-indonesia/ 2022-11-17T12:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/11/G42_3-tJXscT.jpeg https://medicaex.com/prnewswire/sk-biopharmaceuticals-receives-korea-drug-development-fund-investment-grant-to-develop-novel-oncology-candidate-skl27969/ 2022-11-17T10:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-gOfXgl.jpeg https://medicaex.com/prnewswire/cr-research-the-largest-korean-cro-expands-partnership-with-medidata-to-enhance-their-clinical-operations/ 2022-11-17T10:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/3DS_MEDIDATAtype_RGB_Green_Logo-bxYcQo.jpeg https://medicaex.com/prnewswire/winning-the-fight-against-neuropathy-in-diabetic-patients/ 2022-11-17T08:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/PG2-GnRK73.jpeg https://medicaex.com/prnewswire/qmed-asia-eyes-apac-expansion-with-digital-health-solutions/ 2022-11-17T08:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/Regional_Expansion_01-7WY9Bt.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-wins-2022-fierce-life-sciences-innovation-award/ 2022-11-17T07:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/gracell_logo_Logo-eTPTcU.jpeg https://medicaex.com/prnewswire/asia-pacific-experts-uncover-gender-based-disparity-in-diagnosis-treatment-and-management-of-atrial-fibrillation/ 2022-11-17T03:13:25+00:00 https://medicaex.com/prnewswire/ces-2023-ai-for-pet-named-as-ces-2023-innovation-awards-honoree/ 2022-11-17T02:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/TTcare_CES_2023_INNOVATION_AWARD-p6Evbm.jpeg https://medicaex.com/prnewswire/ascletis-announces-ind-approval-of-oral-pd-l1-small-molecule-inhibitor-asc61-for-treatment-of-advanced-solid-tumors-by-china-nmpa/ 2022-11-17T01:12:28+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-named-ces-2023-innovation-awards-honoree/ 2022-11-17T00:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-AfgOAB.jpeg https://medicaex.com/prnewswire/medibeacon-receives-10-million-in-amended-agreements-with-huadong-medicine-to-accelerate-development-of-transdermal-gfr-measurement-system/ 2022-11-17T00:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/11/MediBeacon_Logo-FigKMo.jpeg https://medicaex.com/prnewswire/xiantao-zhengxin-group-introduces-a-fully-automated-mask-production-line-to-expand-production-capacity-reduce-pollution-and-contribute-to-sustainable-development/ 2022-11-17T00:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/11/Zhengxin_Group_Introduces_a_Fully_Automated_Mask_Production_Line_Expand-SleVfG.jpeg https://medicaex.com/prnewswire/nuralogix-researchers-announce-the-capability-to-assess-type-2-diabetes-and-blood-biomarker-health-issues-using-any-video-enabled-device/ 2022-11-16T22:12:39+00:00 https://medicaex.com/prnewswire/emotiv-partners-with-x-trodes-to-launch-new-medical-grade-at-home-solution-for-brain-monitoring-research/ 2022-11-16T22:12:39+00:00 https://medicaex.com/prnewswire/ys-biopharma-received-qualified-person-declaration-for-its-pika-covid-19-vaccine-facility-from-european-union-gmp/ 2022-11-16T22:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/YS_Biopharma_Logo-xqoRDV.jpeg https://medicaex.com/prnewswire/job-groups-mini-fire-extinguishing-system-amfe-receives-seal-of-approval-from-the-insurance-industry/ 2022-11-16T17:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/JOB_Group_AMFE-cGD25W.jpeg https://medicaex.com/prnewswire/meihua-international-medical-technologies-co-limited-reports-unaudited-2022-first-half-financial-results/ 2022-11-16T16:12:39+00:00 https://medicaex.com/prnewswire/landmacy-seeks-to-expand-growth-amid-rising-demand-for-vegan-supplements/ 2022-11-16T16:12:19+00:00 https://medicaex.com/prnewswire/slacom-and-nccn-launch-international-project-to-improve-breast-cancer-care-in-argentina/ 2022-11-16T16:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/NCCN_Logo-y4ggnR.jpeg https://medicaex.com/prnewswire/genscript-probio-enters-strategic-collaboration-with-hibiocy-co-ltd-the-affiliate-of-rojukiss-international-public-company-limited-kiss-the-leading-thai-based-beauty-health-company-for-th/ 2022-11-16T15:12:30+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ms_Worrawan_Chaikamnerd_CEO_Hibiocy_KISS__left__Mr_Johnson_Wang-5KL0RQ.jpeg